Compounds > epirubicin
Page last updated: 2024-08-23

epirubicin and Carcinoma, Bronchogenic

epirubicin has been researched along with Carcinoma, Bronchogenic in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19903 (75.00)18.7374
1990's1 (25.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Blotta, A; Boltri, B; Busutti, L; Casadio, M; Falcone, F; Giordani, S; Lelli, G; Pannuti, F; Ramini, R1
Fritze, D; Harjung, H; Katz, R; Kober, B1
Casadio, M; Giordani, S; Giuliotti, C; Lelli, G; Martoni, A; Pannuti, F; Strocchi, E1
Canova, N; Casadio, M; Giordani, S; Giuliotti, C; Lelli, G; Martoni, A; Pannuti, F1

Other Studies

4 other study(ies) available for epirubicin and Carcinoma, Bronchogenic

ArticleYear
Small cell bronchogenic carcinoma: a cyclical alternating combination of epirubicin plus cisplatin and cyclophosphamide plus etoposide.
    Journal of chemotherapy (Florence, Italy), 1990, Volume: 2, Issue:3

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Cisplatin; Cyclophosphamide; Epirubicin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged

1990
[Results of palliative chemotherapy in advanced small cell bronchial carcinoma].
    Deutsche medizinische Wochenschrift (1946), 1988, Oct-28, Volume: 113, Issue:43

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Cyclophosphamide; Epirubicin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Palliative Care; Prognosis; Retrospective Studies; Vincristine

1988
Phase II studies on weekly cisplatinum plus epirubicin or etoposide in the treatment of advanced non-small cell bronchogenic carcinoma.
    Chemioterapia : international journal of the Mediterranean Society of Chemotherapy, 1986, Volume: 5, Issue:4

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bronchogenic; Carcinoma, Non-Small-Cell Lung; Cisplatin; Doxorubicin; Drug Administration Schedule; Drug Evaluation; Epirubicin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged

1986
4'-Epidoxorubicin plus cisplatin as first-line therapy in the treatment of small cell bronchogenic carcinoma.
    Chemioterapia : international journal of the Mediterranean Society of Chemotherapy, 1987, Volume: 6, Issue:2

    Topics: Adult; Aged; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Cisplatin; Doxorubicin; Epirubicin; Female; Humans; Leukocyte Count; Lung Neoplasms; Male; Middle Aged

1987